1. 5 Things NPs and PAs Need to Know About Tardive Dyskinesia

3. This program will include a discussion of off-label treatments not approved by the FDA for use in the US.

4. Tardive Dyskinesia

5. Clinical Presentation of Tardive Dyskinesia

6. Videos of Patients With Tardive Dyskinesia

7. Subtypes of TD

8. Diagnosis: Clinical Signs and Symptoms

9. Diagnosis: AIMS

10. Scoring the AIMS Procedure and Examples of Movements

11. Scoring the AIMS Global Judgments and Dental Status

12. Pathophysiology of TD

13. Prevalence of TD

14. Risk Factors

15. Prevent Onset and Minimize Risk

16. Treatment of TD Agents Used Prior to 2017

17. Vesicular Monoamine Transporter 2 Inhibitors

18. Tetrabenazine

19. Deutetrabenazine

20. AIM-TD: Deutetrabenazine

21. Valbenazine

22. KINECT 3: Valbenazine

23. Updated AAN Treatment Algorithm

24. Monitoring Patients on VMAT Inhibitors

25. Role of Physician Assistants and Nurse Practitioners in TD Management

26. Practice Pearls for Managing TD

27. Concluding Remarks

28. Abbreviations

29. Abbreviations (cont)